Eustacia Pharmaceuticals Private Limited
About Eustacia Pharmaceuticals Private Limited
Data last updated:
Eustacia Pharmaceuticals Private Limited is a private limited company based in Narigapalli, Andhra Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 07 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U51909AP2016PTC103081. Its GSTIN is 05AAECE2442F1Z4 (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manoj Kumar (Managing Director) and Vinod Kumar.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at D – No 37 – 514 Gopalapuram, Narigapalli, Andhra Pradesh, India – 517002.
As per the financials filed for FY 2020, the company reported a revenue of ₹9.3 Lakh, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹28,256 (net margin 3%) and EBITDA of ₹43,624 (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD – No 37 – 514 Gopalapuram, Narigapalli, Andhra Pradesh, India – 517002
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Eustacia Pharmaceuticals Private Limited FY 2020 filings available
Eustacia Pharmaceuticals Private Limited reported revenue of ₹9.3 Lakh (up 22% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of Eustacia Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 41% over three years, including 22% growth in the latest year. EBITDA rose 133% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Eustacia Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹9.3 Lakh | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹43,624 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹28,256 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Eustacia Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.7% | •••• | •••• | •••• |
| Net Profit Margin | 3% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Eustacia Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Eustacia Pharmaceuticals Private Limited
Eustacia Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Kumar | Director | 07 Apr 2016 | 10 Years 6 Months | Current |
| Manoj Kumar Also directs: Garvin Genetics Limited | Managing Director | 07 Apr 2016 | 10 Years 6 Months | Current |
Auditor Details of Eustacia Pharmaceuticals Private Limited
Eustacia Pharmaceuticals Private Limited is audited by RAMANKUMARSAH for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAMANKUMARSAH | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Eustacia Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Eustacia Pharmaceuticals Private Limited
Eustacia Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Eustacia Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Eustacia Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Eustacia Pharmaceuticals Private Limited
Eustacia Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Manoj Kumar was appointed as Managing Director on 07 Apr 2016.
Credit Ratings, Litigation & Regulatory Alerts for Eustacia Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Eustacia Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Eustacia Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Eustacia Pharmaceuticals Private Limited
Eustacia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAECE2442F1Z4 | Uttarakhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Eustacia Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eustacia Pharmaceuticals Private Limited
Eustacia Pharmaceuticals is an active private limited company based in Narigapalli, Andhra Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 07 April 2016 (10+ years old) and is registered under CIN U51909AP2016PTC103081.
Eustacia Pharmaceuticals reported revenue of ₹9.3 Lakh for FY 2020 (up 22% YoY).
Eustacia Pharmaceuticals has 2 current directors:
- Manoj Kumar - Managing Director
- Vinod Kumar - Director
Eustacia Pharmaceuticals reported a net profit of ₹28,256 (net margin 3%) and EBITDA of ₹43,624 (EBITDA margin 4.7%) for FY 2020, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Eustacia Pharmaceuticals is 41% over three years. In the latest year (FY 2020) revenue rose 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Eustacia Pharmaceuticals is 05AAECE2442F1Z4, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Eustacia Pharmaceuticals is U51909AP2016PTC103081. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eustacia Pharmaceuticals was incorporated on 07 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Vijayawada.
Manoj Kumar was appointed as Managing Director on 07 Apr 2016. Vinod Kumar was appointed as Director on 07 Apr 2016.
The registered office of Eustacia Pharmaceuticals is at D – No 37 – 514 Gopalapuram, Narigapalli, Andhra Pradesh, India – 517002.